Elixinol Wellness Limited
ELLXF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $3 | $5 | $31 | $82 |
| - Cash | $1 | $1 | $2 | $1 |
| + Debt | $3 | $2 | $1 | $1 |
| Enterprise Value | $5 | $6 | $31 | $83 |
| Revenue | $8 | $8 | $7 | $5 |
| % Growth | -6.3% | 20.9% | 40.7% | – |
| Gross Profit | $3 | $3 | $2 | -$1 |
| % Margin | 34.6% | 39.4% | 35.7% | -13.9% |
| EBITDA | -$3 | -$2 | -$2 | -$4 |
| % Margin | -37.3% | -26.1% | -31.8% | -76.9% |
| Net Income | -$3 | $1 | -$3 | -$4 |
| % Margin | -40.4% | 12.6% | -40.7% | -85.4% |
| EPS Diluted | -0.014 | 0.006 | -0.003 | -0.005 |
| % Growth | -348.2% | 300% | 45.1% | – |
| Operating Cash Flow | -$1 | -$1 | -$2 | -$2 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$1 | -$2 | -$2 |